Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
32.98 USD | +4.90% | +34.51% | +59.80% |
May. 24 | Mizuho Securities Starts Cartesian Therapeutics With Buy Rating | MT |
May. 22 | Cartesian Gets Regenerative Medicine Advanced Therapy Label for Myasthenia Gravis Drug Candidate | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+59.80% | 560M | |
+10.63% | 114B | |
+11.33% | 105B | |
-2.64% | 23.83B | |
-1.37% | 21.73B | |
-9.77% | 18.1B | |
-42.36% | 16.34B | |
-15.37% | 16.13B | |
+2.16% | 13.75B | |
+33.93% | 11.76B |
- Stock Market
- Equities
- RNAC Stock
- News Cartesian Therapeutics, Inc.
- Needham Adjusts Price Target on Selecta Biosciences to $4 From $5, Maintains Buy Rating